Market Research Logo

Psoriasis - Current and Future Players

Psoriasis - Current and Future Players

Summary

GlobalData has released its pharma report, “Psoriasis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Psoriasis Market. The report identifies and analyses the key companies shaping and driving the global Psoriasis market. The report provides insight into the competitive Psoriasis landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope

  • Investigation of current and future market competition for Psoriasis
  • Competitor assessment
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of Psoriasis sector through market impact analysis, future market scenario and company analysis
Reasons to buy
  • Gain a high level view of the trends shaping and driving Psoriasis market
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market
  • What’s the next big thing in the global Psoriasis market landscape? Identify, understand and capitalize


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Related Reports
3 Market Outlook
3.1 Global Markets
3.1.1 Forecast
3.1.2 Drivers and Barriers - Global Issues
4 Current and Future Players
4.1 Overview
4.2 Trends in Corporate Strategy
4.3 Company Profiles
4.3.1 Johnson & Johnson
4.3.2 AbbVie
4.3.3 Amgen
4.3.4 Novartis
4.3.5 Pfizer
4.3.6 Eli Lilly
4.3.7 Merck
4.3.8 LEO Pharma
4.3.9 Celgene
4.3.10 Can-Fite Biopharma
5 Appendix
5.1 Bibliography
5.2 Abbreviations
5.3 Methodology
5.4 Forecasting Methodology
5.4.1 Diagnosed Psoriasis Patients
5.4.2 Percent Drug-Treated Patients
5.4.3 Drugs Included in Each Therapeutic Class
5.4.4 Launch and Patent Expiry Dates
5.4.5 General Pricing Assumptions
5.4.6 Individual Drug Assumptions
5.4.7 Generic Erosion
5.4.8 Pricing of Pipeline agents
5.5 Physicians and Specialists Included in this Study
5.6 Primary Research - Prescriber Survey
5.7 About the Authors
5.7.1 Author
5.7.2 Reviewer
5.7.3 Epidemiologist
5.7.4 Global Director of Therapy Analysis and Epidemiology
5.7.5 Global Head of Healthcare
5.8 About GlobalData
5.9 Disclaimer
1.1 List of Tables
Table 1: Global Sales Forecast ($m) for Psoriasis, 2014-2024
Table 2: Global Psoriasis Market - Drivers and Barriers, 2014-2024
Table 3: Key Companies in the Psoriasis Market, 2014
Table 4: J&J’s Psoriasis Portfolio Assessment, 2015
Table 5: J&J’s Psoriasis Portfolio SWOT Analysis, 2015
Table 6: AbbVie’s Psoriasis Portfolio Assessment, 2015
Table 7: AbbVie’s Psoriasis SWOT Analysis, 2015
Table 8: Amgen’s Psoriasis Portfolio Assessment, 2015
Table 9: Amgen’s Psoriasis SWOT Analysis, 2015
Table 10: Novartis’s Psoriasis Portfolio Assessment, 2015
Table 11: Novartis’ Psoriasis SWOT Analysis, 2015
Table 12: Pfizer’s Psoriasis Portfolio Assessment, 2015
Table 13: Pfizer’s Psoriasis Portfolio SWOT Analysis, 2015
Table 14: Eli Lilly’s Psoriasis Portfolio Assessment, 2015
Table 15: Eli Lilly’s Psoriasis Portfolio SWOT Analysis, 2015
Table 16: Merck’s Psoriasis Portfolio Assessment, 2015
Table 17: Merck’s Psoriasis Portfolio SWOT Analysis, 2015
Table 18: LEO Pharma’s Psoriasis Portfolio Assessment, 2015
Table 19: LEO Pharma’s Psoriasis Portfolio SWOT Analysis, 2015
Table 20: Celgene’s Psoriasis Portfolio Assessment, 2015
Table 21: Celgene’s Psoriasis Portfolio SWOT Analysis, 2015
Table 22: Celgene’s Psoriasis Portfolio Assessment, 2015
Table 23: Celgene’s Psoriasis Portfolio SWOT Analysis, 2015
Table 24: Key Launch Dates
Table 25: Key Patent Expiries
Table 26: Key Launch Dates
Table 27: Physicians Surveyed, by Country
1.2 List of Figures
Figure 1: Global Sales for Psoriasis by Region, 2014-2024
Figure 2: Company Portfolio Gap Analysis in Psoriasis, 2014-2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report